Compared with its close competitors within the same industry, KOSDAQ, since the monthly volatility of CTC BIO was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.1%. By tumbling of stock price, return-on-risk is the lowest among its peer group in spite of low volatility. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -6.0, and thus the industrial comparison performance was not so good.
Close Competitors | Earning rate (%)
Revenue |
Financial structure Overview
P/E ratio and P/B ratio
Institutions and Foreigners sell, Individuals buy
From Oct. 17, institutions have been continously selling CTC BIO during the past five trading days. As a shareholding sum by investor group for the past four weeks, foreigners have sold 16,731 shares and institutions have sold 199,129 shares with a selling trend. However, during the same period, individuals have bought 215,860 shares with an increasing position.
From Oct. 17, institutions have been continously selling CTC BIO during the past five trading days. As a shareholding sum by investor group for the past four weeks, foreigners have sold 16,731 shares and institutions have sold 199,129 shares with a selling trend. However, during the same period, individuals have bought 215,860 shares with an increasing position.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.